Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux

Bormio Nunes, Julia H., Hager, Sonja, Mathuber, Marlene, Pósa, Vivien, Roller, Alexander, Enyedy, Éva Anna, Stefanelli, Alessia, Berger, Walter, Keppler, Bernhard K., Heffeter, Petra, Kowol, Christian R.: Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux.
JOURNAL OF MEDICINAL CHEMISTRY, 63. pp. 13719-13732. ISSN 0022-2623 (2020)

[img]
Preview
Text
31661639.pdf - Published Version

Download (5MB) | Preview
Item Type: Article
Journal or Publication Title: JOURNAL OF MEDICINAL CHEMISTRY
Date: 2020
Volume: 63
Page Range: pp. 13719-13732
ISSN: 0022-2623
Faculty: Faculty of Science and Informatics
Institution: Szegedi Tudományegyetem
MTMT id: 31661639
DOI id: https://doi.org/10.1021/acs.jmedchem.0c01277
Date Deposited: 2020. Dec. 14. 12:24
Last Modified: 2020. Dec. 14. 12:24
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/20066

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year